Rahul Sharma (Editor)

Nanjing Ange Pharmaceutical

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Headquarters
  
Nanjing, China

Number of employees
  
35 (2007)

Founded
  
2003

Industry
  
Pharmaceuticals, Healthcare

Products
  
Antineoplastic medicine, pharmaceutical intermediates

Motto
  
"Quality Technology and Service Foster Healthy Life"

Nanjing Ange Pharmaceutical Co., Ltd. (simplified Chinese: 南京安格医药化工有限公司; traditional Chinese: 南京安格醫藥化工有限公司; pinyin: Nánjīng āngé yīyào huàgōng yǒuxiàn gōngsī) is a pharmaceutical company in Nanjing, in the People's Republic of China, specializing in the development of “New Drugs” (the drugs that previously have not been marketed in China, i.e., New Chemical Entities for China's FDA) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.

Contents

Company Profile

Ange was founded in 2003, and is now a leading company in the Chinese pharmaceutical industry. With almost every major university in Nanjing Ange has established cooperative relationships and laboratories, including China Pharmaceutical University, China’s first independent school of pharmacy and one of the few institutes with complete pharmaceutical fields.

Main Products

Ange's main products are Antineoplastic medicines, which include:

  • Sunitinib
  • Lapatinib
  • Nilotinib
  • Dasatinib
  • Gefitinib
  • Erlotinib
  • Imatinib
  • Canertinib
  • It also produces relative pharmaceutical intermediates.

    Recent Projects

    In the past 2 years, Ange has been working with Abbott Laboratories Ltd. and Simcere Pharmaceutical Group, etc.

    References

    Nanjing Ange Pharmaceutical Wikipedia